title: Prevention of 1,2-dimethylhydrazine-induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis.
abstract: We have performed this study to investigate the modulatory effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, a bisdemethoxy curcumin analog (BDMCA) on circulatory lipid peroxidation (LPO) and antioxidant status during 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in male Wistar rats. The effects were compared with that of the reference drug, curcumin. Increased tumor incidence as well as enhanced LPO in the circulation of tumor bearing rats was accompanied by a significant decrease in the level of reduced glutathione and activities of glutathione peroxidase (GPx), glutathione S-transferase (GST), superoxide dismutase (SOD) and catalase (CAT). Intragastric administration of BDMCA or curcumin to DMH-treated rats significantly decreased colon tumor incidence and the circulatory LPO, with simultaneous enhancement of GSH content and GPx, GST, SOD and CAT activities. We report that BDMCA exert its chemopreventive effect by decreasing the colon tumor incidence as well as by modulating circulatory oxidative stress in DMH-treated rats through its influence on LPO and antioxidant status. The effects of BDMCA were comparable with that of the reference compound curcumin, a well known anticarcinogen and antioxidant. Thus, it would be suggested that the methoxy group is not responsible for the beneficial effects, however, the terminal phenolic moieties or the central 7-carbon chain may play a role.
authors.affiliation: Department of Biotechnology, Mother Teresa Women's University, Kodaikanal 624 102, Tamil Nadu, India. tdevasenabio@yahoo.com
authors.forename: Thiyagarajan
authors.initials: T
authors.lastname: Devasena
authors.forename: Venugopal P
authors.initials: VP
authors.lastname: Menon
authors.forename: Kallikat N
authors.initials: KN
authors.lastname: Rajasekharan
mesh_terms: D019813:1,2-Dimethylhydrazine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000477:Alkylating Agents / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000139:chemically induced* / Q000378:metabolism* / Q000473:pathology; D003474:Curcumin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
chemical_list: D000477:Alkylating Agents; D016588:Anticarcinogenic Agents; D000975:Antioxidants; D017392:Thiobarbituric Acid Reactive Substances; C514299:bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione; D003474:Curcumin; D019813:1,2-Dimethylhydrazine